Europe · Markets & Finance · Option Finance

AstraZeneca, Daiichi Sankyo et Summit s'associent dans de nouveaux essais contre le cancer

Published by Option Finance · France 1 d ago

Summit Therapeutics va collaborer avec AstraZeneca et Daiichi Sankyo pour évaluer une combinaison de Datroway et de son traitement ivonescimab contre plusieurs tumeurs solides,…

Read the full article on Option Finance Sign in to save

MediaNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.optionfinance.fr)

Also worth reading

Financial Times

China launches anti-dumping probe into European chemical exports

This is Money

Our neighbour's broken wall is pushing over our garden fence, but she refuses to repair it. What can we do?

City A.M.

Is Soho nightlife really dead? We went partying to find out

Reuters Markets

Japan shifts messaging to counter view its policies are reflationary, Katayama says in TV interview

MoneyWeek

8 of the best houses for sale with stables

Reuters Sustainability